Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-09-21
1984-09-18
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424246, 42424857, 2602433, 544 60, 544115, 544251, A61K 31505, C07D48704
Patent
active
044724004
ABSTRACT:
Novel triazoloquinazolones of the formula ##STR1## wherein R and R' are individually selected from the group consisting of hydrogen, halogen, nitro and alkyl and alkoxy of 1 to 3 carbon atoms, Y is selected from the group consisting of alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 4 carbon atoms, cycloalkyl of 3 to 8 carbon atoms, aryl of 6 to 8 carbon atoms and aralkyl of 7 to 8 carbon atoms, B is an alkylene of 1 to 3 carbon atoms, X is selected from the group consisting of ##STR2## R.sub.1 and R.sub.2 are individually selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 8 carbon atoms, aryl of 6 to 8 carbon atoms, aralkyl of 7 to 8 carbon atoms, aminoalkyl of 2 to 4 carbon atoms, mono- and dialkylaminoalkyl with each alkyl having 2 to 4 carbon atoms, piperidinoalkyl of 1 to 4 alkyl carbon atoms, morpholinoalkyl of 1 to 4 alkyl carbon atoms and piperazinylalkyl of 1 to 4 alkyl carbon atoms or R.sub.1 and R.sub.2 taken together with the nitrogen to which they are attached form a saturated mono- or bicyclic heterocyclic ring with 4 to 8 carbon atoms optionally substituted with 1 to 2 methyls and optionally containing in the ring a heteroatom selected from --O--, --S-- and ##STR3## and R.sub.3 is selected from the group consisting of hydrogen, alkyl of 1 to 3 carbon atoms, hydroxyalkyl of 1 to 3 carbon atoms, alkoxycarbonyl of 2 to 5 carbon atoms, aryl of 6 to 8 carbon atoms and aralkyl of 7 to 8 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having antihistaminic and bronchospasmolytic activity and their preparation and intermediates.
REFERENCES:
patent: 4002755 (1977-01-01), Yamamoto et al.
patent: 4145419 (1979-03-01), Rolands et al.
patent: 4151280 (1979-04-01), Rowlands et al.
patent: 4207318 (1980-06-01), Rolands et al.
patent: 4254123 (1981-03-01), Ramm et al.
patent: 4279912 (1981-07-01), Ager et al.
patent: 4291033 (1981-09-01), Barnes et al.
patent: 4333934 (1982-06-01), Barnes et al.
Kottke, et al., Chemical Abstracts, vol. 89, 129470v, (1978).
Renner, et al., Chemical Abstracts, vol. 94, No. 17, 132238j, (04/27/81).
Clements-Jewery Stephen
Rowlands David A.
Tully Wilfred R.
Westwood Robert
Daus Donald G.
Muserlian Charles A.
Rivers Diana G.
Roussel Uclaf
LandOfFree
Triazoloquinazolones having antihistaminic and bronchospasmolyti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazoloquinazolones having antihistaminic and bronchospasmolyti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazoloquinazolones having antihistaminic and bronchospasmolyti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-793639